AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Tufton Oceanic Assets Limited

Notice of Dividend Amount Jul 27, 2018

6605_rns_2018-07-27_84206c2b-2a1d-4bd8-be88-3bde4ee880ed.html

Notice of Dividend Amount

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9339V

Tufton Oceanic Assets Ltd.

27 July 2018

27 July 2018

TUFTON OCEANIC ASSETS LIMITED

("Tufton Oceanic Assets" or the "Company")

Net Asset Value, Dividend Declaration and Q2 2018 Update

Tufton Oceanic Assets announces that as at 30 June 2018 the unaudited net asset value ("NAV") was c.USD 92.5 million and the unaudited NAV per ordinary share was USD1.016.

The Company is pleased to announce its maiden dividend of USD0.015 per ordinary share for the quarter ending 30 June 2018. The dividend will be paid on 17 August 2018 to holders of ordinary shares recorded on the register as at close of business on 10 August 2018 with an ex-dividend date of 9 August 2018.

The Company's quarterly factsheet as at 30 June 2018 will shortly be available on the Company's website in the Investor Relations section under Company Documents at www.tuftonoceanicassets.com/company-documents.

For further information, please contact:

Tufton Oceanic Limited (Investment Manager)

Andrew Hampson

Paulo Almeida
+44 (0) 20 7518 6700
N+1 Singer                  

James Maxwell / Liz Yong (Corporate Finance)

Alan Geeves, James Waterlow, Sam Greatrex (Sales)
+44 (0) 20 7496 3000
Hudnall Capital LLP               

Andrew Cade
+44 (0) 20 7520 9085

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCLLFIRDLIRFIT

Talk to a Data Expert

Have a question? We'll get back to you promptly.